1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Gaia Grow Corp.

Gaia Grow Corp.

GAIA.CN
Gaia Grow Corp.CA flagCanadian Securities Exchange
0.01
CAD
- -
- -
177,170.00Market Cap
Gaia Grow Corp.
GAIA.CN
(Canadian Securities Exchange)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2019
2020
2021
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
Revenue per Share
- -
-0.36
-0.11
-0.12
-0.1
-0.07
-0.13
-0.13
-0.86
-0.69
-0.57
-0.56
Basic EPS, GAAP
- -
-0.11
-0.12
-0.12
-0.1
-0.07
-0.04
-0.13
-0.79
-0.12
-0.17
-0.08
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.4
-0.4
-0.43
-0.54
0.22
0.53
0.97
1.38
0.05
-0.07
-0.08
Book Value per Share
- -
1.52
0.98
0.86
0.76
0.31
0.58
1.02
1.45
0.08
-0.04
-0.06
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
1
1
4
9
12
15
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-32,160.62
-1,432.08
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
-3
-6
-7
-8
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-97,653.13
-6,324.86
Profit Margin (%)
- -
- -
- -
- -
- -
- -
1
1
6
1
- -
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
LT Debt
- -
- -
- -
- -
- -
- -
1
1
6
1
-1
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-39.49
-16.89
-107.84
-203.67
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'22
Jun'22
Sep'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
18
Market Capitalization
44
30
2

Working Capital

FRC

•

in mil. unless spec.
Mar'22
Jun'22
Sep'22
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
75.76%
126.39%
-167.96%
Free Cash Flow
- -
582.14%
86.59%
Net Income, GAAP
- -
658.78%
5.1%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.03
-0.17
-0.02
- -
-0.69
2021
-0.03
-0.05
- -
- -
-0.57
2022
-0.03
-0.18
-0.02
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Similar Companies
ZIM Laboratories Limited (ZIMLAB.BO)
Procaps Group S.A. (PROC)
Hempstract, Inc. (HPST)
Laurus Labs Limited (LAURUSLABS.BO)
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1558.HK)
ViaDerma, Inc. (VDRM)
Business
Gaia Grow Corp. operates as an integrated licensed hemp company headquartered in Vancouver, Canada, founded in the early 21st century. The company specializes in the cultivation of industrial hemp primarily for medical purposes, leveraging a contract farming business model that utilizes existing farmland and skilled farmers. Its core products and services include hemp cultivation, cannabis and hemp processing, extraction of cannabinoids such as THC and CBD, product formulation, novel product development, toll processing, and white label manufacturing of cannabis THC and CBD products. Gaia Grow also operates in the cannabis retail segment with plans for expansion in British Columbia. Recent major developments include strategic expansions in its processing capabilities and product offerings, particularly through its wholly owned subsidiary Tru Extracts, which completed the development of specialized extraction services. The company has also engaged in collaborations and strategic alignments that enhance its production and distribution capacities in the Canadian market. Operationally, Gaia Grow has focused on enhancing its integrated hemp supply chain to support scalable growth, reflecting a broader business expansion within the hemp and cannabis industry. Gaia Grow serves customers primarily in Canada, operating under regulated licenses for hemp and cannabis farming and processing. Its business segments span industrial hemp cultivation for fiber and cannabinoids, cannabis retail, and product development in health and wellness categories derived from hemp. The company sustains its operations through a model that balances agricultural production with advanced processing technologies to deliver a range of hemp-based products, including concentrates, isolates, and formulated cannabis products, to both medical and consumer markets. The company’s recent corporate actions and operational strategy position it for growth within the evolving hemp and cannabis industries in North America, emphasizing sustainable agricultural practices, product innovation, and expansion of retail presence. Gaia Grow’s integrated approach from seed to product supports its objective to capitalize on the increasing demand for hemp-derived products and medical cannabis solutions. Gaia Grow Corp. is publicly listed under the ticker GAIA.CN on the Canadian Securities Exchange and maintains a focus on advancing its footprint in the regulated hemp and cannabis markets through continuous product innovation and expansion of strategic partnerships.